New EHF guideline on the use of MAb’s for migraine prevention Session 4: Difficult to treat patientsSimona Sacco Previous Patient FAQs & demands and how to address Next Comorbidities and management You Might Also Like Rationale for switching of preventative treatments Multidisciplinary management Epidemiology The outlook of a tertiary treatment and research center Treatment response as a biomarker
New EHF guideline on the use of MAb’s for migraine prevention Session 4: Difficult to treat patientsSimona Sacco Previous Patient FAQs & demands and how to address Next Comorbidities and management You Might Also Like Rationale for switching of preventative treatments Multidisciplinary management Epidemiology The outlook of a tertiary treatment and research center Treatment response as a biomarker
